Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00035035
Status:
COMPLETED
Last Update Posted:
2006-07-19
First Post:
2002-05-02
Brief Title:
A Phase 3 Trial of ALIMTA LY231514 Pemetrexed Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company